BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Conjeevaram HS, Lok AS. Occult hepatitis B virus infection: a hidden menace? Hepatology. 2001;34:204-206. [PMID: 11431752 DOI: 10.1053/jhep.2001.25225] [Cited by in Crossref: 105] [Cited by in F6Publishing: 108] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Chemin I, Trépo C. Clinical impact of occult HBV infections. J Clin Virol. 2005;34 Suppl 1:S15-S21. [PMID: 16461218 DOI: 10.1016/s1386-6532(05)80005-8] [Cited by in Crossref: 105] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
2 Chen C, Changchien C, Lee C, Tung W, Hung C, Hu T, Wang J, Wang J, Lu S. A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan. Int J Cancer 2009;125:621-9. [DOI: 10.1002/ijc.24416] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
3 Song SH, Hwang SG. [Occult hepatitis B virus infection: transmission and reactivation]. Korean J Gastroenterol 2013;62:148-53. [PMID: 24077624 DOI: 10.4166/kjg.2013.62.3.148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
4 Lee SY, Choi MS, Lee D, Lee JH, Koh KC, Paik SW, Yoo BC. Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy. J Korean Med Sci 2005;20:433-7. [PMID: 15953865 DOI: 10.3346/jkms.2005.20.3.433] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
5 El-Zaatari M, Kazma H, Naboulsi-Majzoub M, Haidar M, Ramlawi F, Mahfoud Z, Ramia S. Hepatitis B virus DNA in serum of 'anti-HBc only'-positive healthy Lebanese blood donors: significance and possible implications. J Hosp Infect 2007;66:278-82. [PMID: 17540476 DOI: 10.1016/j.jhin.2007.04.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pazienza V, Niro GA, Fontana R, Vinciguerra M, Andriulli A. Advance in molecular diagnostic tools for hepatitis B virus detection. Clin Chem Lab Med 2013;51:1707-17. [PMID: 23612658 DOI: 10.1515/cclm-2013-0136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
7 Ramos CA, Saliba RM, de Pádua Silva L, Khorshid O, Shpall EJ, Giralt S, Patah PA, Hosing CM, Popat UR, Rondon G, Nieto Y, Champlin RE, de Lima M. Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010;16:686-94. [PMID: 20056165 DOI: 10.1016/j.bbmt.2009.12.532] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
8 Carmel R, Sarrai M. Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies. Curr Hematol Rep 2006;5:23-33. [PMID: 16537043 DOI: 10.1007/s11901-006-0019-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
9 Kim DH, Kim SB. Hepatic Failure by Spontaneous Reactivation of Hepatitis B Virus without a Trigger Factor in a Patient with Anti-HBs. Case Rep Gastroenterol 2018;12:286-91. [PMID: 30022917 DOI: 10.1159/000490099] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
10 Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, Burroughs AK. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl. 2006;12:1049-1061. [PMID: 16799946 DOI: 10.1002/lt.20824] [Cited by in Crossref: 204] [Cited by in F6Publishing: 175] [Article Influence: 13.6] [Reference Citation Analysis]
11 Neau D, Winnock M, Galpérine T, Jouvencel AC, Castéra L, Legrand E, Tranchant E, Balestre E, Lacoste D, Ragnaud JM, Dupon M, Lafon ME, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA). Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. HIV Med 2004;5:171-3. [PMID: 15139983 DOI: 10.1111/j.1468-1293.2004.00206.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
12 Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, Levrero M, Raimondo G. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology. 2007;45:277-285. [PMID: 17256766 DOI: 10.1002/hep.21529] [Cited by in Crossref: 109] [Cited by in F6Publishing: 107] [Article Influence: 7.8] [Reference Citation Analysis]
13 Alhababi F, Sallam TA, Tong CY. The significance of 'anti-HBc only' in the clinical virology laboratory. J Clin Virol 2003;27:162-9. [PMID: 12829038 DOI: 10.1016/s1386-6532(02)00171-3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
14 Kwak MS, Kim YJ. Occult hepatitis B virus infection. World J Hepatol. 2014;6:860-869. [PMID: 25544873 DOI: 10.4254/wjh.v6.i12.860] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
15 Ramezani A, Aghasadeghi MR, Ahmadi F, Razeghi E, Eslamifar A, Banifazl M, Sofian M, Bahramali G, Hekmat S, Aghakhani A. Isolated anti-hbc and occult HBV infection in dialysis patients. Nephrourol Mon. 2015;7:e22674. [PMID: 25738121 DOI: 10.5812/numonthly.22674] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
16 Coffin CS, Pham TN, Mulrooney PM, Churchill ND, Michalak TI. Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection. Hepatology. 2004;40:1053-1061. [PMID: 15382154 DOI: 10.1002/hep.20419] [Cited by in Crossref: 19] [Cited by in F6Publishing: 29] [Article Influence: 1.1] [Reference Citation Analysis]
17 Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, Ramezani A. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Int J Infect Dis 2010;14:e308-10. [PMID: 19656713 DOI: 10.1016/j.ijid.2009.05.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
18 Liu CJ, Chen PJ, Shau WY, Kao JH, Lai MY, Chen DS. Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study. Liver Int. 2003;23:148-155. [PMID: 12955877 DOI: 10.1034/j.1600-0676.2003.00820.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
19 Sobaniec-Lotowska ME, Lebensztejn DM. Ultrastructure of hepatocyte mitochondria in nonalcoholic steatohepatitis in pediatric patients: usefulness of electron microscopy in the diagnosis of the disease. Am J Gastroenterol. 2003;98:1664-1665. [PMID: 12873608 DOI: 10.1111/j.1572-0241.2003.07561.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
20 Ferreira MS, Borges AS. [Advances in the treatment of hepatitis B]. Rev Soc Bras Med Trop 2007;40:451-62. [PMID: 17876470 DOI: 10.1590/s0037-86822007000400016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
21 Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13:3730-3733. [PMID: 17659734 DOI: 10.3748/wjg.v13.i27.3730] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
22 Kamimura H, Watanabe J, Sugano T, Kohisa J, Abe H, Kamimura K, Tsuchiya A, Takamura M, Okoshi S, Tanabe Y, Takagi R, Nonaka H, Terai S. Relationship between detection of hepatitis B virus in saliva and periodontal disease in hepatitis B virus carriers in Japan. J Infect Chemother 2021;27:492-6. [PMID: 33183962 DOI: 10.1016/j.jiac.2020.10.028] [Reference Citation Analysis]
23 Lok AS. Occult hepatitis B virus infection: diagnosis, implications and management? J Gastroenterol Hepatol 2004;19:S114-7. [DOI: 10.1111/j.1440-1746.2004.03657.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
24 Liang SH, Chen TJ, Lee SS, Tseng FC, Huang CK, Lai CH, Chiou CP, Wang JL, Chung HC, Lin JN. Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection. J Acquir Immune Defic Syndr. 2010;54:122-128. [PMID: 20386111 DOI: 10.1097/qai.0b013e3181daafd5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
25 Tan HH, Martin P. Management of end-stage liver disease in chronic hepatitis B. Clin Liver Dis. 2010;14:477-493. [PMID: 20638026 DOI: 10.1016/j.cld.2010.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
26 Wen X, Su H, Wang Y, Pu Z, Gao J, Ji Z, Yuan X, Li X, Zhang W, Zhang L, Long Y, Yan Y, Shao Z. Prevalence and natural course of occult hepatitis B virus infection in residents of 2 communities of Wuwei City, Gansu Province, China. J Viral Hepat 2018;25:281-8. [DOI: 10.1111/jvh.12805] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J 2016;13:76. [PMID: 27150469 DOI: 10.1186/s12985-016-0533-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
28 Colomina-rodríguez J, González-garcía D, Burgos-teruel A, Fernández-lorenz N, Guerrero-espejo A. Significado de la reactividad aislada anti-HBc como único marcador de infección de la hepatitis B. Enfermedades Infecciosas y Microbiología Clínica 2005;23:80-5. [DOI: 10.1157/13071611] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
29 Michalak TI, Mulrooney PM, Coffin CS. Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver. J Virol. 2004;78:1730-1738. [PMID: 14747538 DOI: 10.1128/jvi.78.4.1730-1738.2004] [Cited by in Crossref: 74] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
30 Bereket-Yücel S. Risk of hepatitis B infections in Olympic wrestling. Br J Sports Med 2007;41:306-10; discussion 310. [PMID: 17331974 DOI: 10.1136/bjsm.2006.032847] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
31 Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology. 2004;127:1356-1371. [PMID: 15521005 DOI: 10.1053/j.gastro.2004.08.003] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 6.2] [Reference Citation Analysis]
32 Raimondo G, Allain J, Brunetto MR, Buendia M, Chen D, Colombo M, Craxì A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky J, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trépo C, Villa E, Will H, Zanetti AR, Zoulim F. Statements from the Taormina expert meeting on occult hepatitis B virus infection. Journal of Hepatology 2008;49:652-7. [DOI: 10.1016/j.jhep.2008.07.014] [Cited by in Crossref: 513] [Cited by in F6Publishing: 487] [Article Influence: 39.5] [Reference Citation Analysis]
33 Burton JR Jr, Shaw-Stiffel TA. Use of hepatitis B core antibody-positive donors in recipients without evidence of hepatitis B infection: a survey of current practice in the United States. Liver Transpl. 2003;9:837-842. [PMID: 12884197 DOI: 10.1053/jlts.2003.50157] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
34 Minuk GY, Sun DF, Uhanova J, Zhang M, Caouette S, Nicolle LE, Gutkin A, Doucette K, Martin B, Giulivi A. Occult hepatitis B virus infection in a North American community-based population. J Hepatol. 2005;42:480-485. [PMID: 15763333 DOI: 10.1016/j.jhep.2004.11.037] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 4.1] [Reference Citation Analysis]
35 Laperche S, Thibault V, Bouchardeau F, Alain S, Castelain S, Gassin M, Gueudin M, Halfon P, Larrat S, Lunel F, Martinot-Peignoux M, Mercier B, Pawlotsky JM, Pozzetto B, Roque-Afonso AM, Roudot-Thoraval F, Sauné K, Lefrère JJ. Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study. J Clin Microbiol 2006;44:3600-7. [PMID: 17021089 DOI: 10.1128/JCM.00732-06] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
36 Kim YS. [Definition, diagnosis, and prevalence of occult hepatitis B virus infection]. Korean J Gastroenterol 2013;62:143-7. [PMID: 24077623 DOI: 10.4166/kjg.2013.62.3.143] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
37 Ikeda K, Kobayashi M, Someya T, Saitoh S, Hosaka T, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study. J Viral Hepat. 2009;16:437-443. [PMID: 19226331 DOI: 10.1111/j.1365-2893.2009.01085.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
38 Ghisetti V, Marzano A, Zamboni F, Barbui A, Franchello A, Gaia S, Marchiaro G, Salizzoni M, Rizzetto M. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance. Liver Transpl. 2004;10:356-362. [PMID: 15004761 DOI: 10.1002/lt.20093] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
39 Sagnelli E, Pasquale G, Coppola N, Marrocco C, Scarano F, Imparato M, Sagnelli C, Scolastico C, Piccinino F. Liver histology in patients with HBsAg negative anti-HBc and anti-HCV positive chronic hepatitis. J Med Virol 2005;75:222-6. [DOI: 10.1002/jmv.20260] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
40 Urbani S, Fagnoni F, Missale G, Franchini M. The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med. 2010;48:23-29. [PMID: 19919328 DOI: 10.1515/cclm.2010.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
41 Chen MH, Hsiao LT, Chiou TJ, Liu JH, Gau JP, Teng HW, Wang WS, Chao TC, Yen CC, Chen PM. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Ann Hematol 2008;87:475-80. [PMID: 18327583 DOI: 10.1007/s00277-008-0469-9] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 4.9] [Reference Citation Analysis]
42 Motta JS, Mello FC, Lago BV, Perez RM, Gomes SA, Figueiredo FF. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis. J Gastroenterol Hepatol. 2010;25:101-106. [PMID: 19817965 DOI: 10.1111/j.1440-1746.2009.05972.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
43 Chung SM, Sohn JH, Kim TY, Yoo KD, Ahn YW, Bae JH, Jeon YC, Choi JH. [Fulminant hepatic failure with hepatitis B virus reactivation after rituximab treatment in a patient with resolved hepatitis B]. Korean J Gastroenterol. 2010;55:266-269. [PMID: 20389182 DOI: 10.4166/kjg.2010.55.4.266] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
44 Chandra PK, Biswas A, Datta S, Banerjee A, Panigrahi R, Chakrabarti S, De BK, Chakravarty R. Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection. J Viral Hepat. 2009;16:749-756. [PMID: 19457142 DOI: 10.1111/j.1365-2893.2009.01129.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
45 Kim H, Lee SA, Kim DW, Lee SH, Kim BJ. Naturally occurring mutations in large surface genes related to occult infection of hepatitis B virus genotype C. PLoS One 2013;8:e54486. [PMID: 23349904 DOI: 10.1371/journal.pone.0054486] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
46 Lo Re V 3rd, Wertheimer B, Localio AR, Kostman JR, Dockter J, Linnen JM, Giachetti C, Dorey-Stein Z, Frank I, Strom BL, Gross R. Incidence of transaminitis among HIV-infected patients with occult hepatitis B. J Clin Virol 2008;43:32-6. [PMID: 18486540 DOI: 10.1016/j.jcv.2008.03.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
47 Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2007; 5: 938-945, 945.e1-945. e4. [PMID: 17509946 DOI: 10.1016/j.cgh.2007.02.039] [Cited by in Crossref: 140] [Cited by in F6Publishing: 123] [Article Influence: 10.0] [Reference Citation Analysis]
48 Kwon OS, Jung YK, Bae KS, Kim JH, Kim SG, Kim YS, Lee JI, Lee JW, Kim YS. Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: a case-control study. Alcohol 2012;46:537-41. [PMID: 22572059 DOI: 10.1016/j.alcohol.2012.03.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
49 Datta S, Banerjee A, Chandra PK, Chowdhury A, Chakravarty R. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers. J Med Virol. 2006;78:53-59. [PMID: 16299727 DOI: 10.1002/jmv.20503] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
50 Raimondo G, Pollicino T, Squadrito G. Clinical virology of hepatitis B virus infection. Journal of Hepatology 2003;39:26-30. [DOI: 10.1016/s0168-8278(03)00135-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
51 Valsamakis A. Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev. 2007;20:426-439, table of contents. [PMID: 17630333 DOI: 10.1128/cmr.00009-07] [Cited by in Crossref: 86] [Cited by in F6Publishing: 31] [Article Influence: 6.1] [Reference Citation Analysis]
52 Bowden S, Bartholomeusz A, Locarnini S. Lamivudine resistant occult HBV: implications for public health? J Hepatol. 2003;38:526-528. [PMID: 12663248 DOI: 10.1016/s0168-8278(03)00079-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
53 Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis]. Korean J Hepatol. 2008;14:67-76. [PMID: 18367859 DOI: 10.3350/kjhep.2008.14.1.67] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
54 Fang Y, Shang Q, Liu J, Li D, Xu W, Teng X, Zhao H, Fu L, Zhang F, Gu H. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. Journal of Infection 2009;58:383-8. [DOI: 10.1016/j.jinf.2009.02.013] [Cited by in Crossref: 54] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
55 Pianigiani E, Risulo M, Ierardi F, Sbano P, Andreassi L, Fimiani M, Caudai C, Valensin PE, Zazzi M. Prevalence of skin allograft discards as a result of serological and molecular microbiological screening in a regional skin bank in Italy. Burns 2006;32:348-51. [DOI: 10.1016/j.burns.2005.10.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
56 Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol. 2007;46:160-170. [PMID: 17112622 DOI: 10.1016/j.jhep.2006.10.007] [Cited by in Crossref: 335] [Cited by in F6Publishing: 318] [Article Influence: 22.3] [Reference Citation Analysis]
57 Fabrizi F, Lunghi G, Martin P, Poordad F. Serological and Molecular Testing in Hepatitis B and the Dialysis Patient. Int J Artif Organs 2002;25:91-9. [DOI: 10.1177/039139880202500203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Vaezjalali M, Rashidpour S, Rezaee H, Hajibeigi B, Zeidi M, Gachkar L, Aghamohamad S, Najafi R, Goudarzi H. Hepatitis B viral DNA among HBs antigen negative healthy blood donors. Hepat Mon. 2013;13:e6590. [PMID: 23675384 DOI: 10.5812/hepatmon.6590] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
59 Vivekanandan P, Singh OV. Molecular methods in the diagnosis and management of chronic hepatitis B. Expert Rev Mol Diagn 2010;10:921-35. [PMID: 20964611 DOI: 10.1586/erm.10.75] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
60 Marrero JA, Lok AS. Occult hepatitis B virus infection in patients with hepatocellular carcinoma: Innocent bystander, cofactor, or culprit. Gastroenterology. 2004;126:347-350. [PMID: 14699513 DOI: 10.1053/j.gastro.2003.11.021] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
61 Kim SJ, Moon JH, Kim H, Kim JS, Hwang YY, Intragumtornchai T, Issaragrisil S, Kwak JY, Lee JJ, Won JH. Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group. Leuk Lymphoma. 2012;53:1515-1524. [PMID: 22273250 DOI: 10.3109/10428194.2012.659735] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
62 Ramia S, Mokhbat J, Ramlawi F, El-Zaatari M. Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen. Int J STD AIDS. 2008;19:197-199. [PMID: 18397562 DOI: 10.1258/ijsa.2007.007200] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
63 Huang MA, Lok AS. Natural history of hepatitis B and outcomes after liver transplantation. Clin Liver Dis 2003;7:521-36. [PMID: 14509524 DOI: 10.1016/s1089-3261(03)00054-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanemitsu K, Nishioka K; the Japanese Red Cross NAT Screening Research Group. Hepatitis B NAT virus-positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Vox Sang 2005;88:77-86. [DOI: 10.1111/j.1423-0410.2005.00602.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 3.8] [Reference Citation Analysis]
65 Kim H, Gong JR, Lee SA, Kim BJ. Discovery of a Novel Mutation (X8Del) Resulting in an 8-bp Deletion in the Hepatitis B Virus X Gene Associated with Occult Infection in Korean Vaccinated Individuals. PLoS One. 2015;10:e0139551. [PMID: 26437447 DOI: 10.1371/journal.pone.0139551] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
66 Fang Y, Teng X, Xu WZ, Li D, Zhao HW, Fu LJ, Zhang FM, Gu HX. Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C. J Med Virol. 2009;81:826-835. [PMID: 19319940 DOI: 10.1002/jmv.21463] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
67 Yoo JH, Hwang SG, Yang DH, Son MS, Kwon CI, Ko KH, Hong SP, Park PW, Rim KS. Prevalence of occult hepatitis B virus infection in hemodialysis patients. Korean J Gastroenterol 2013;61:209-14. [PMID: 23624735 DOI: 10.4166/kjg.2013.61.4.209] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
68 Hashemi SJ, Hajiani E, Masjedizadeh A, Makvandi M, Shayesteh AA, Alavinejad SP, Kadkhodaei A, Shahbazian H, Jasemi F, Karimi M. Occult hepatitis B infection in patients with cryptogenic liver cirrhosis in southwest of Iran. Jundishapur J Microbiol. 2015;8:e16873. [PMID: 25861432 DOI: 10.5812/jjm.16873] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
69 Fabrizi F, Messa PG, Lunghi G, Aucella F, Bisegna S, Mangano S, Villa M, Barbisoni F, Rusconi E, Martin P. Occult hepatitis B virus infection in dialysis patients: a multicentre survey. Aliment Pharmacol Ther 2005;21:1341-7. [PMID: 15932364 DOI: 10.1111/j.1365-2036.2005.02501.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
70 Liu C, Chen D, Chen P. Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT. Journal of Clinical Virology 2006;36:S33-44. [DOI: 10.1016/s1386-6532(06)80007-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
71 Kim EB, Kim DS, Park SJ, Park Y, Rho KH, Kim SJ. Hepatitis B virus reactivation in a surface antigen-negative and antibody-positive patient after rituximab plus CHOP chemotherapy. Cancer Res Treat 2008;40:36-8. [PMID: 19688064 DOI: 10.4143/crt.2008.40.1.36] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
72 Lo Re V, Frank I, Gross R, Dockter J, Linnen JM, Giachetti C, Tebas P, Stern J, Synnestvedt M, Localio AR. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients. J Acquir Immune Defic Syndr. 2007;44:315-320. [PMID: 17159655 DOI: 10.1097/qai.0b013e31802ea499] [Cited by in Crossref: 47] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
73 Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol. 2004;2:87-106. [PMID: 15017613 DOI: 10.1016/s1542-3565(03)00312-4] [Cited by in Crossref: 153] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
74 Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A, Farinati F, Missale G, Smedile A, Tiribelli C, Villa E, Raimondo G. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology. 2004;126:102-110. [PMID: 14699492 DOI: 10.1053/j.gastro.2003.10.048] [Cited by in Crossref: 300] [Cited by in F6Publishing: 286] [Article Influence: 17.6] [Reference Citation Analysis]
75 Barros Júnior GM, Braga WS, Oliveira CM, Castilho Mda C, Araújo Jde R. [Occult hepatitis B: prevalence and clinical characteristics in a population with high endemicity of hepatitis B infection in the western Brazilian Amazon region]. Rev Soc Bras Med Trop 2008;41:596-601. [PMID: 19142439 DOI: 10.1590/s0037-86822008000600010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
76 Hui C, Sun J, Au W, Lie AK, Yueng Y, Zhang H, Lee NP, Hou J, Liang R, Lau GK. Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. Journal of Hepatology 2005;42:813-9. [DOI: 10.1016/j.jhep.2005.01.018] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 4.3] [Reference Citation Analysis]
77 Selim HS, Abou-donia HA, Taha HA, El Azab GI, Bakry AF. Role of occult hepatitis B virus in chronic hepatitis C patients with flare of liver enzymes. European Journal of Internal Medicine 2011;22:187-90. [DOI: 10.1016/j.ejim.2010.12.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
78 Elghannam DM, Aly RM, Goda EF, Eltoraby EE, Farag RE. Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients. Asian J Transfus Sci 2009;3:14-7. [PMID: 20041091 DOI: 10.4103/0973-6247.45256] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
79 Chakravarty R, Neogi M, Roychowdhury S, Panda CK. Presence of hepatitis B surface antigen mutant G145R DNA in the peripheral blood leukocytes of the family members of an asymptomatic carrier and evidence of its horizontal transmission. Virus Res. 2002;90:133-141. [PMID: 12457969 DOI: 10.1016/s0168-1702(02)00147-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
80 Kleinman S, Chan P, Robillard P. Risks associated with transfusion of cellular blood components in canada. Transfusion Medicine Reviews 2003;17:120-62. [DOI: 10.1053/tmrv.2003.50009] [Cited by in Crossref: 175] [Cited by in F6Publishing: 142] [Article Influence: 9.7] [Reference Citation Analysis]
81 Jain P. DNA-guided hepatitis B treatment: viral load is insufficient with few exceptions. World J Gastroenterol 2009;15:1530-1. [PMID: 19322931 DOI: 10.3748/wjg.15.1530] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
82 Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, Khadem-Sadegh A, Velayati AA. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals. Int J STD AIDS. 2009;20:336-338. [PMID: 19386971 DOI: 10.1258/ijsa.2008.008377] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
83 Jang JY, Jeong SW, Cheon SR, Lee SH, Kim SG, Cheon YK, Kim YS, Cho YD, Kim HS, Jin SY. Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients. Korean J Hepatol. 2011;17:206-212. [PMID: 22102387 DOI: 10.3350/kjhep.2011.17.3.206] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
84 Shetty K, Hussain M, Nei L, Reddy KR, Lok AS. Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C. Liver Transpl. 2008;14:534-540. [PMID: 18324677 DOI: 10.1002/lt.21284] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
85 Gou L, Sheng Y, Peng Q, Ling J, Yue H, Chen F, Tang H. Ternary nanocube-based “off-on” blinking-type electrochemiluminescence towards enzyme-free detection of hepatitis B virus (HBV)-related DNA. Sensors and Actuators B: Chemical 2020;312:127987. [DOI: 10.1016/j.snb.2020.127987] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
86 Kim H, Kim BJ. Association of preS/S Mutations with Occult Hepatitis B Virus (HBV) Infection in South Korea: Transmission Potential of Distinct Occult HBV Variants. Int J Mol Sci. 2015;16:13595-13609. [PMID: 26084041 DOI: 10.3390/ijms160613595] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
87 Santos EA, Yoshida CF, Rolla VC, Mendes JM, Vieira IF, Arabe J, Gomes SA. Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 2003;22:92-8. [PMID: 12627282 DOI: 10.1007/s10096-002-0868-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
88 Sucupira MV, Mello FC, Santos EA, Niel C, Rolla VC, Arabe J, Gomes SA. Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations. Mem Inst Oswaldo Cruz. 2006;101:655-660. [PMID: 17072479 DOI: 10.1590/s0074-02762006000600013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
89 Núñez M, Ríos P, Pérez-Olmeda M, Soriano V. Lack of 'occult' hepatitis B virus infection in HIV-infected patients. AIDS 2002;16:2099-101. [PMID: 12370518 DOI: 10.1097/00002030-200210180-00024] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 3.2] [Reference Citation Analysis]
90 Liu CJ, Kao JH, Chen DS. Clinical significance of occult hepatitis B virus infection cannot be overlooked. Clin Infect Dis 2006;42:583-4. [PMID: 16421814 DOI: 10.1086/500016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
91 Torres-baranda R, Bastidas-ramírez BE, Maldonado-gonzález M, Sánchez-orozco LV, Vázquez-vals E, Rodríguez-noriega E, Panduro A. Occult hepatitis B in mexican patients with HIV, an analysis using nested polymerase chain reaction. Annals of Hepatology 2006;5:34-40. [DOI: 10.1016/s1665-2681(19)32037-x] [Cited by in Crossref: 17] [Article Influence: 1.1] [Reference Citation Analysis]
92 Shaw T, Bowden S, Locarnini S. Chemotherapy for hepatitis B: new treatment options necessitate reappraisal of traditional endpoints. Gastroenterology. 2002;123:2135-2140. [PMID: 12454868 DOI: 10.1053/gast.2002.37288] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
93 Neau D, Winnock M, Jouvencel AC, Faure M, Castéra L, Legrand E, Lacoste D, Ragnaud JM, Dupon M, Fleury H. Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003. Clin Infect Dis. 2005;40:750-753. [PMID: 15714424 DOI: 10.1086/427882] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
94 Jang JY, Park EJ. [Occult hepatitis B virus infection in chronic hepatitis C]. Korean J Gastroenterol 2013;62:154-9. [PMID: 24077625 DOI: 10.4166/kjg.2013.62.3.154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
95 Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion. 2005;45:1247-1257. [PMID: 16078909 DOI: 10.1111/j.1537-2995.2005.00198.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 4.9] [Reference Citation Analysis]
96 Mu SC, Lin YM, Jow GM, Chen BF. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol. 2009;50:264-272. [PMID: 19070923 DOI: 10.1016/j.jhep.2008.09.017] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 5.5] [Reference Citation Analysis]
97 Hui C, Lau E, Monto A, Kim M, Luk JM, Poon RTP, Leung N, Lo C, Fan S, Lau GKK, Wright TL. Natural History of Patients with Recurrent Chronic Hepatitis C Virus and Occult Hepatitis B Co-Infection after Liver Transplantation.: In 118 patients with viral and histologic evidence of recurrent hepatitis C infection coinfected with occult hepatitis B virus after liver transplantation, the occult hepatitis B virus coinfection was not associated with accelerated fibrosis. Am J Transplant 2006;6:1600-8. [DOI: 10.1111/j.1600-6143.2006.01370.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
98 Lin C, Liu C, Chen P, Lai M, Chen D, Kao J. High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users. J Med Virol 2007;79:1674-8. [DOI: 10.1002/jmv.20985] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
99 Mhalla S, Hammoud R, Frih A, Kadri Y, El Argoubi A, Elmay M, Mastouri M. Prevalence and risk factors of hepatitis B and C among hemodialysis patients in Tunisia. Med Mal Infect 2018;48:175-9. [PMID: 29249466 DOI: 10.1016/j.medmal.2017.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
100 Hui CK, Cheung WW, Zhang HY, Au WY, Yueng YH, Leung AY, Leung N, Luk JM, Lie AK, Kwong YL. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology. 2006;131:59-68. [PMID: 16831590 DOI: 10.1053/j.gastro.2006.04.015] [Cited by in Crossref: 350] [Cited by in F6Publishing: 303] [Article Influence: 23.3] [Reference Citation Analysis]
101 Banerjee A, Chandra PK, Datta S, Biswas A, Bhattacharya P, Chakraborty S, Chakrabarti S, Bhattacharya SK, Chakravarty R. Frequency and significance of hepatitis B virus surface gene variant circulating among ‘antiHBc only’ individuals in Eastern India. J Clin Virol. 2007;40:312-317. [PMID: 17997353 DOI: 10.1016/j.jcv.2007.08.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
102 Fabrizi F, Bunnapradist S, Lunghi G, Villa M, Martin P. Transplanting Solid Organs from HBsAg Negative Donors Positive for Antibody to Hepatitis B Core Antigen: The Implications. The International Journal of Artificial Organs 2018;26:972-83. [DOI: 10.1177/039139880302601102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
103 Vamvakas EC, Blajchman MA. Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Transfus Med Rev 2010;24:77-124. [PMID: 20303034 DOI: 10.1016/j.tmrv.2009.11.001] [Cited by in Crossref: 116] [Cited by in F6Publishing: 90] [Article Influence: 10.5] [Reference Citation Analysis]
104 Shi YH, Shi CH. Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol. 2009;15:3099-3105. [PMID: 19575488 DOI: 10.3748/wjg.15.3099] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
105 Shire AM, Roberts LR. Occult hepatitis B virus infection: bit player or role player? Hepatology. 2011;54:760-763. [PMID: 21735471 DOI: 10.1002/hep.24528] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
106 Yang YT, Huang AL, Zhao Y. The prevalence of hepatitis B core antibody in vaccinated Chinese children: A hospital-based study. Vaccine 2019;37:458-63. [PMID: 30527659 DOI: 10.1016/j.vaccine.2018.11.067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
107 Hernandez BY, Zhu X, Kwee S, Chan OT, Tsai N, Okimoto G, Horio D, McGlynn KA, Altekruse S, Wong LL. Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2013;22:2016-23. [PMID: 23983238 DOI: 10.1158/1055-9965.EPI-13-0397] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
108 Kampfrath T, Jortani SA, Levinson SS. Resolving a case of concurrent hepatitis B virus surface antigen (HBsAg) and surface antibody (HBsAb). Clinica Chimica Acta 2014;430:171-2. [DOI: 10.1016/j.cca.2014.01.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]